Literature DB >> 20566978

Physician attitudes toward industry: a view across the specialties.

Deborah Korenstein1, Salomeh Keyhani, Joseph S Ross.   

Abstract

OBJECTIVES: To explore attitudes of physicians from all specialties toward gifts from and interactions with the pharmaceutical and medical device industries.
DESIGN: Anonymous, cross-sectional survey distributed and collected between June 1 and September 1, 2008.
SETTING: Hospitals in the Mount Sinai School of Medicine consortium in the New York, New York, metropolitan area. PARTICIPANTS: Faculty and trainee physicians from all clinical departments. MAIN OUTCOME MEASURES: Attitudes toward industry interactions and gifts and their appropriateness measured on 4-point Likert scales.
RESULTS: A total of 590 physicians and medical students completed the survey (response rate, 67.0%); 351 (59.5%) were male, 230 (39.0%) were attending physicians, and 131 (23.7%) of 553 (excluding medical students) were from surgical specialties. Attitudes toward industry and gifts were generally positive: 72.2% found sponsored lunches appropriate, whereas 25.4% considered large gifts appropriate. Surgeons, trainees, and those unfamiliar with institutional policies on industry interactions held more positive attitudes than others and were more likely to deem some gifts appropriate, including industry funding of residency programs and, among surgeons, receiving meals, travel expenses, and payments for attending lectures. Nonattending physicians held more positive attitudes toward receiving meals in clinical settings, textbooks, and samples.
CONCLUSIONS: Physicians continue to hold positive attitudes toward marketing-oriented activities of the pharmaceutical and device industries. Changes in medical culture and physician education focused on surgeons and trainees may align physician attitudes with current policy trends.

Entities:  

Mesh:

Year:  2010        PMID: 20566978      PMCID: PMC2891545          DOI: 10.1001/archsurg.2010.75

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  20 in total

1.  Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions.

Authors:  M A Steinman; M G Shlipak; S J McPhee
Journal:  Am J Med       Date:  2001-05       Impact factor: 4.965

2.  Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior.

Authors:  B B McCormick; G Tomlinson; P Brill-Edwards; A S Detsky
Journal:  JAMA       Date:  2001 Oct 24-31       Impact factor: 56.272

Review 3.  Ethical guidelines for orthopaedists and industry.

Authors:  Charles H Epps
Journal:  Clin Orthop Relat Res       Date:  2003-07       Impact factor: 4.176

4.  Are gifts from pharmaceutical companies ethically problematic? A survey of physicians.

Authors:  Allan S Brett; Wayne Burr; Jamaluddin Moloo
Journal:  Arch Intern Med       Date:  2003-10-13

5.  Effects of an educational intervention on residents' knowledge and attitudes toward interactions with pharmaceutical representatives.

Authors:  J A Hopper; M W Speece; J L Musial
Journal:  J Gen Intern Med       Date:  1997-10       Impact factor: 5.128

6.  Financial conflicts of interest in physicians' relationships with the pharmaceutical industry--self-regulation in the shadow of federal prosecution.

Authors:  David M Studdert; Michelle M Mello; Troyen A Brennan
Journal:  N Engl J Med       Date:  2004-10-28       Impact factor: 91.245

7.  A prospective before-and-after trial of an educational intervention about pharmaceutical marketing.

Authors:  Sacha Agrawal; Inderpal Saluja; Janusz Kaczorowski
Journal:  Acad Med       Date:  2004-11       Impact factor: 6.893

8.  Medical students' exposure to pharmaceutical industry marketing: a survey at one U.S. medical school.

Authors:  Melena Bellin; Susan McCarthy; Laurel Drevlow; Claus Pierach
Journal:  Acad Med       Date:  2004-11       Impact factor: 6.893

9.  Medical students' exposure to and attitudes about drug company interactions: a national survey.

Authors:  Frederick S Sierles; Amy C Brodkey; Lynn M Cleary; Frederick A McCurdy; Matthew Mintz; Julia Frank; D Joanne Lynn; Jason Chao; Bruce Z Morgenstern; William Shore; John L Woodard
Journal:  JAMA       Date:  2005-09-07       Impact factor: 56.272

Review 10.  Pharmaceutical industry marketing: understanding its impact on women's health.

Authors:  Carolyn B Sufrin; Joseph S Ross
Journal:  Obstet Gynecol Surv       Date:  2008-09       Impact factor: 2.347

View more
  17 in total

1.  Editorial: Is It Time to End Surgeon-Industry Consulting?

Authors:  Seth S Leopold
Journal:  Clin Orthop Relat Res       Date:  2015-07-07       Impact factor: 4.176

2.  Health Professionals "Make Their Choice": Pharmaceutical Industry Leaders' Understandings of Conflict of Interest.

Authors:  Quinn Grundy; Lisa Tierney; Christopher Mayes; Wendy Lipworth
Journal:  J Bioeth Inq       Date:  2017-09-14       Impact factor: 1.352

3.  The relationship between paediatric practitioners and 'industry'.

Authors:  Susan Albersheim; Kevin Coughlin
Journal:  Paediatr Child Health       Date:  2017-08-11       Impact factor: 2.253

4.  Types and Distribution of Payments From Industry to Physicians in 2015.

Authors:  Kathryn R Tringale; Deborah Marshall; Tim K Mackey; Michael Connor; James D Murphy; Jona A Hattangadi-Gluth
Journal:  JAMA       Date:  2017-05-02       Impact factor: 56.272

5.  Adherence of pharmaceutical advertisements in medical journals to FDA guidelines and content for safe prescribing.

Authors:  Deborah Korenstein; Salomeh Keyhani; Ali Mendelson; Joseph S Ross
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

6.  GPs' opinions of public and industrial information regarding drugs: a cross-sectional study.

Authors:  Ingmarie Skoglund; Cecilia Björkelund; Kirsten Mehlig; Ronny Gunnarsson; Margareta Möller
Journal:  BMC Health Serv Res       Date:  2011-08-25       Impact factor: 2.655

7.  TRENDS IN INTRAVITREAL CORTICOSTEROID AGENT USE BY US OPHTHALMOLOGISTS IN MEDICARE BENEFICIARIES AND ASSOCIATION WITH PHYSICIAN-INDUSTRY INTERACTIONS.

Authors:  Arjun Watane; Meghana Kalavar; Nicolas A Yannuzzi; Ajay E Kuriyan; Jayanth Sridhar
Journal:  Retina       Date:  2021-08-01       Impact factor: 3.975

8.  Chronological changes in Japanese physicians' attitude and behavior concerning relationships with pharmaceutical representatives: a qualitative study.

Authors:  Sayaka Saito; Kei Mukohara; Yasushi Miyata
Journal:  PLoS One       Date:  2014-09-19       Impact factor: 3.240

9.  Salespeople in the Surgical Suite: Relationships between Surgeons and Medical Device Representatives.

Authors:  Bonnie O'Connor; Fran Pollner; Adriane Fugh-Berman
Journal:  PLoS One       Date:  2016-08-03       Impact factor: 3.240

10.  Attitudes and relationship between physicians and the pharmaceutical industry in a public general hospital in Lima, Peru.

Authors:  Aldo De Ferrari; Cesar Gentille; Long Davalos; Leandro Huayanay; German Malaga
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.